MARKET

IHE

IHE

iShares US Pharmaceuticals ETF
NYSEARCA
66.21
-0.40
-0.59%
Closed 16:00 06/14 EDT
OPEN
66.40
PREV CLOSE
66.61
HIGH
66.56
LOW
65.95
VOLUME
17.97K
TURNOVER
0
52 WEEK HIGH
69.56
52 WEEK LOW
54.77
TOTAL ASSET
685.00M
YTD YIELD
14.28%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at IHE last week (0603-0607)?
Weekly Report · 6d ago
What The 2024 Elections Could Mean For Health Care Investors
Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.
Seeking Alpha · 06/08 06:20
Friday's ETF Movers: IHE, SIL
NASDAQ · 06/07 16:12
How Is Johnson & Johnson's Stock Performance Compared to Other Pharmaceutical Stocks?
Johnson & Johnson (JNJ) is a global healthcare powerhouse valued at $355.71 billion by market cap. Shares of JNJ are currently trading 17.1% below their 52-week high of $175.97. The stock has declined 8.8% over the past three months, underperforming the iShares U.S. Pharmaceuticals ETF.
Barchart · 06/06 10:12
Weekly Report: what happened at IHE last week (0527-0531)?
Weekly Report · 06/03 12:08
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
NASDAQ · 06/03 10:20
Do Wall Street Analysts Like Eli Lilly Stock?
Shares of Eli Lilly and Company (LLY) have outshined the broader market over the past year. The drug maker has outperformed the broader S&P 500 Index ($SPX) over the same period. Eli Lilly stock has a consensus "Strong Buy" rating overall.
Barchart · 05/31 09:05
Weekly Report: what happened at IHE last week (0520-0524)?
Weekly Report · 05/27 12:15
More
Profile
Fund Name
iShares US Pharmaceuticals ETF
Inception Date
2006-05-01
Benchmark
DJ US Select Pharms TR USD
Advisor Company
BlackRock Fund Advisors
Custodian
Citibank NA
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead